KRAS and lung adenocarcinoma: Conservation of this programme in KRAS<sup>G12D</sup>-inducible human alveolar organoids and early-stage lung adenocarcinoma tissues identifies epithelial-microenvironment communication as a therapeutically actionable vulnerability and suggests that intercepting niche formation may prevent progression to treatment-resistant disease.